One double-blind , randomized , vehicle-controlled study ( study 1 ) and two open-label studies ( studies 2 and 3 ) examined the efficacy , safety , and optimal dosing concentration of tavaborole topical solution applied once daily or three times weekly for 180 days at concentrations of 1.0 % , 2.5 % , 5.0 % , or 7.5 % .